SAN DIEGO, April 29, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AppLovin Corporation (NASDAQ: APP) securities between May 10, 2023 and February 25, 2025, both dates inclusive (the "Class Period"), have until Monday, May 5, 2025 to seek appointment as lead plaintiff of the AppLovin class action lawsuit. Captioned Quiero v. AppLovin Corporation, Inc., No. 25-cv-02294 (N.D. Cal.), the AppLovin class action lawsuit charges AppLovin and certain of AppLovin's e ...

Highlights SoFi’s platform is gaining momentum, adding 800,000 new members and 1.2 million new products, representing 34% and 35% year-on-year growth, respectively. Personal loan borrowers have a weighted average income of $158,000 and a weighted average FICO score of 743. SoFi is diversifying its offerings and increasing fee-based revenue. SoFi Technologies posted first-quarter earnings results Tuesday (April 29) that showed continued growth in deposits and debit spending, as well as a roadmap ...

Group 1 - The Ordinary and Extraordinary Shareholders' Meeting of SCOR SE was held on April 29, 2025, where all resolutions proposed by the Board of Directors were approved [2][3] - Shareholders approved a dividend payment of EUR 1.80 per share for the 2024 financial year, with the ex-dividend date set for May 2, 2025, and payment scheduled for May 6, 2025 [2] - The terms of office for directors Fabrice Brégier, Martine Gerow, and Fields Wicker-Miurin were renewed, and Diane Côté and Doina Palici-Chehab were appointed as new directors [3] Group 2 - SCOR generated premiums of EUR 20.1 billion in 2024 and serves clients in over 150 countries from 37 offices worldwide [5]

Sirius XM (SIRI) is scheduled to report its first-quarter 2025 results on May 1.See the Zacks Earnings Calendar to stay ahead of market-making news.The Zacks Consensus Estimate for SIRI’s first-quarter 2025 revenues is currently pegged at $2.08 billion, indicating a 3.66% decrease from the year-ago quarter’s reported figure.The consensus mark for earnings has remained unchanged at 70 cents per share in the past 30 days. The estimate implies no year-over-year change.SIRI surpassed the Zacks Consensus Estimat ...

Company Overview - Meta Platforms is the world's largest social media platform operator, evolving from Facebook to a diverse operator through acquisitions like Instagram and WhatsApp [1] - Approximately 97% of Meta's revenues come from advertising, facing competition from companies like Alphabet, Amazon, and Snap [2] Earnings Preview - Meta is set to report earnings on April 30, with shares down about 8% year-to-date but up approximately 27% over the past year and 171% over the past five years [3] - The options market indicates a potential move of plus or minus 9.2% following the earnings report [4] Earnings Expectations - Zacks Consensus Analyst Estimates project earnings growth of roughly 10.83% for the current quarter, with flat growth expected for 2025 [5] - Current quarter earnings estimate is $5.22, with a high estimate of $5.85 and a low estimate of $4.81 [8] Earnings Surprise History - Meta has a strong history of exceeding Wall Street expectations, with positive surprises in nine consecutive quarters and an average surprise of 13.77% over the past four quarters [9] Valuation - The recent correction in Meta's shares has made the stock cheaper, trading at approximately 23 times earnings, near its lowest valuation in two years [11] AI Integration - Meta is leveraging AI across its platforms, enhancing user engagement and optimizing ads, with significant integration in WhatsApp and Messenger [14] - AI optimization has led to a 24% increase in time spent on Instagram, with 40% of content curated through AI [15] Conclusion - Despite recent challenges, Meta has established itself as a leader in social media, with a strong earnings track record and a forward-looking approach to AI integration, indicating a bullish outlook for the company [16]

Core Insights - The Q1 2025 earnings cycle is heavily focused on guidance, influenced by recent economic uncertainties and tariff announcements [1][9] - Several companies, including Centene, Boston Scientific, and Celestica, have raised their guidance, indicating positive performance [2][17] Centene (CNC) - Centene reported an adjusted EPS of $2.90 and sales of $46.6 billion, exceeding consensus estimates with a year-over-year earnings growth of 28% [3] - The company raised its 2025 premium and service revenues guidance by $6.0 billion, reflecting a 17% year-over-year improvement [3][6] - Analysts now expect Centene to post $172.8 billion in revenues for the current fiscal year, with a favorable Zacks Rank 2 (Buy) [6] Boston Scientific (BSX) - Boston Scientific surpassed both top and bottom line expectations, achieving a 12% EPS beat and sales 2.3% above expectations [8] - The company now anticipates FY25 sales growth between 15% and 17%, with current year sales expectations adjusted to $19.4 billion, a 10% increase from the previous year [10] Celestica (CLS) - Celestica exceeded Zacks Consensus EPS estimates by 8% and reported sales nearly 4% ahead of expectations, with a year-over-year sales growth of 20% [12] - The company raised its full-year 2025 revenue outlook to $10.85 billion from $10.7 billion, expecting non-GAAP adjusted EPS of $5.00, up from $4.75 [13] - Strong demand for solutions amid the AI trend and a shift to higher-margin products contributed to Celestica's stellar performance [13]

Financial Performance - The company's net profit for the year 2024 is EUR 8,135,864 [1] - The company's retained earnings for the year 2024 are EUR 6,811,856 [1] Profit Distribution - A decision on the distribution of the company's profits will be made by 15 May this year [2] - The Government of the Republic of Lithuania will decide on the reduction of dividends paid by UAB Valstybės investicinis kapitalas for the shares owned by the State [2] Governance - The rights of the general shareholders' meeting are exercised, and all shares of UAB Valstybės investicinis kapitalas are managed by the Ministry of Finance [2]

NEWPORT BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), today announced the filing of four novel patent applications for its two candidates EL-22 and EL-32. These patent applications cover the animal market, as well as treating muscle loss in obese patients, both as standalone and combination therapies alongside GLP-1 receptor agonists. The Company filed the following fo ...

Novo Nordisk A/S NVO and Hims & Hers Health, Inc. HIMS announced a long-term collaboration on Tuesday.In March, Novo Nordisk introduced NovoCare Pharmacy, a direct-to-patient delivery service to improve access to Wegovy (semaglutide) for cash-paying patients.Americans can now access NovoCare Pharmacy directly through the Hims & Hers platform. A bundled offering of all dose strengths of Wegovy and a Hims & Hers membership, which includes access to 24/7 care, ongoing clinical support, and nutrition guidance.I ...

Fly Play hf.: Financial Results Q1 2025 PLAY’s business plan continues to progress, with a clear focus on our most stable and profitable business segments: leisure and ACMI operations. Cash position strengthened to USD 21.1 million at the end of Q1 2025, up from USD 17.2 million. Operating costs in Q1 2025 were USD 58 million, compared to USD 66 million in Q1 2024. PLAY carried 286 thousand passengers in Q1 2025, compared to 349 thousand in Q1 2024. Load factor in Q1 2025 was 77.2%, compared to 81.8% in Q1 ...